Back to search

Article

A novel twelve-gene signature to evaluate neoadjuvant chemotherapy response and predict prognosis in breast cancer

2022-08-02

Abstract excerpt

<h4>Background: </h4> Accurate evaluation of breast cancer response to neoadjuvant chemotherapy (NAC) provides important information about systemic therapies, which elucidates tumor biology and prognosis and guides further therapies. Gene profiles overcome the limitations of some indicators of the classical pathological evaluation criteria and the subjectivity of observation, but are complicated and expensive. The...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
867d8688-ca9d-533c-83ee-e0df8fd55575
DOI
10.21203/rs.3.rs-1308081/v2
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
A novel twelve-gene signature to evaluate neoadjuvant chemotherapy response and predict prognosis in breast cancerDOI 10.21203/rs.3.rs-1308081/v2
A novel gene signature to predict response to neoadjuvant chemotherapy and endocrine treatment in estrogen receptor-positive breast cancer patientsSemantic proximity
Novel Gene Signatures Predictive of Patient Recurrence-free Survival in HR+HER2- Breast CancerSemantic proximity
The construction of a breast cancer prognostic model by combining genes related to hypoxia and endoplasmic reticulum stress.Semantic proximity
Identification of A 10-Gene Signature To Predict Efficacy of Neoadjuvant Therapy in Patients With HER2 Positive Breast Cancer.Semantic proximity
Transcriptomic Analysis of Breast Cancer Patients Sensitive and Resistant to Chemotherapy: Looking for Overall Survival and Drug Resistance BiomarkersSemantic proximity
Identification of a novel gene signature with DDR and EMT difunctionalities for predicting prognosis, immune activity, and drug response in breast cancerSemantic proximity
Identifying Hub Genes Associated with Neoadjuvant Chemotherapy Resistance in Breast Cancer and Potential Drug Repurposing for the Development of Precision MedicineSemantic proximity
Identification of a 10-Gene Signature Model to Predict Efficacy of Neoadjuvant Therapy in Patients With HER2&nbsp;Positive Breast Cancer.Semantic proximity
Identification and validation of a novel prognostic signature with DNA methylation-driven genes for survival prediction of breast cancerSemantic proximity
Identification and validation of molecular subtypes and a 9-gene risk model for breast cancer.Semantic proximity
Gene expression profile analysis to discover molecular signatures for early diagnosis and therapies of triple-negative breast cancerSemantic proximity
Transcriptomic analysis of breast cancer patients sensitive and resistant to chemotherapy: Looking for overall survival and drug resistance biomarkersSemantic proximity
Select a neighboring publication to make it the new centre.